Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Julia Kollewe and Mark Sweney

Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Packs of Wegovy
Novo Nordisk’s value has slumped by more than 60% over the past year, with studies showing Eli Lilly’s weight loss drug is more effective. Photograph: Reuters

The Danish maker of the weight-loss and diabetes drugs Wegovy and Ozempic is to cut 9,000 jobs as it slashed its profit forecast again, amid fierce competition from its US rival Eli Lilly.

Novo Nordisk’s decision to cut 11% of its global workforce of 78,400 is an attempt by the new chief executive, Mike Doustdar, to revive its fortunes.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.